Improved preparation of amyloid-β peptides using DBU as Nα-Fmoc deprotection reagent

被引:82
作者
Tickler, AK
Barrow, CJ
Wade, JD [1 ]
机构
[1] Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
关键词
Alzheimer's disease; amyloid-beta peptides; aspartimide; continuous flow Fmoc solid phase peptide synthesis; DBU; purification;
D O I
10.1002/psc.342
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have shown the amyloid peptides, A beta 1-40/42, to be exceptionally difficult to assemble by Fmoc-solid phase peptide synthesis due to the high hydrophobicity of the C-terminal segment and resulting on-resin aggregation. We found that the use of the stronger and more efficient base, DBU. at a concentration of 2% in DMF for N-alpha-Fmoc deprotection allowed substantially improved continuous flow solid phase assembly of the model peptide A beta 29-40/42 fragments. This suggested that. at least for these sequences. incomplete deprotection was a greater problem than Incomplete amino acid acylation. This base was then used during the synthesis of both A beta 1-40 and A beta 1-42, up to and including Ser(8), from which point 20% piperidine in DMF was utilized so as to avoid potential aspartimide formation at Asp(7). By this means, the deprotection efficiency through the difficult C-terminal portion of the sequence was much improved and resulted in increased availability of terminal amino groups for acylation. This simple strategy that obviates the need for special conditions significantly improved crude peptide quality and allowed considerable facilitation of subsequent purification. Copyright (C) 2001 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 37 条
[1]  
Albericio F, 2000, SOLID-PHASE SYNTHESIS, P275
[2]  
Atherton E., 1989, SOLID PHASE PEPTIDE
[3]   SOLUTION STRUCTURES OF BETA PEPTIDE AND ITS CONSTITUENT FRAGMENTS - RELATION TO AMYLOID DEPOSITION [J].
BARROW, CJ ;
ZAGORSKI, MG .
SCIENCE, 1991, 253 (5016) :179-182
[4]  
BEDFORD J, 1992, INT J PEPT PROT RES, V40, P300
[5]   Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches [J].
Behl, C .
PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) :301-323
[6]  
Carr D. B., 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)00262-3
[7]  
Clippingdale AB, 2001, J PEPT SCI, V7, P227
[8]  
Dettin M, 1997, J PEPT RES, V49, P103
[9]   PIPERIDINE-MEDIATED SIDE PRODUCT FORMATION FOR ASP(OBU(T))-CONTAINING PEPTIDES [J].
DOLLING, R ;
BEYERMANN, M ;
HAENEL, J ;
KERNCHEN, F ;
KRAUSE, E ;
FRANKE, P ;
BRUDEL, M ;
BIENERT, M .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (07) :853-854
[10]   Oligomerization and toxicity of β-amyloid-42 implicated in Alzheimer's disease [J].
El-Agnaf, OMA ;
Mahil, DS ;
Patel, BP ;
Austen, BM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) :1003-1007